SEC Form 4 research
| Issuer | Tango Therapeutics, Inc. |
|---|---|
| Tickers | TNGX, BCTG |
| Reporting owners | 41 |
| Officers and directors | 5 |
| Last public filing | 2026-10-05 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-05 | 2026-10-01 | Crystal Adam | S | 600 | $25.32 | Not reported |
| 2026-10-05 | 2026-10-01 | Crystal Adam | S | 26,400 | $24.45 | Not reported |
| 2026-09-24 | 2026-09-22 | Newcomb Jessica | S | 2,400 | $25.17 | Not reported |
| 2026-09-24 | 2026-09-22 | Newcomb Jessica | S | 5,100 | $23.97 | Not reported |
| 2026-09-24 | 2026-09-22 | Newcomb Jessica | S | 700 | $22.8 | Not reported |
| 2026-09-03 | 2026-09-01 | Crystal Adam | S | 27,000 | $22.37 | Not reported |
| 2026-08-05 | 2026-08-03 | Crystal Adam | S | 21,733 | $27.35 | Not reported |
| 2026-08-05 | 2026-08-03 | Crystal Adam | S | 5,267 | $26.79 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.